Growing community of inventors

Geneva, Switzerland

Justyna Iwaszkiewicz

Average Co-Inventor Count = 8.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Justyna IwaszkiewiczMartine Cerutti (4 patents)Justyna IwaszkiewiczVincent Zoete (4 patents)Justyna IwaszkiewiczJean Kadouche (4 patents)Justyna IwaszkiewiczOlivier Michielin (4 patents)Justyna IwaszkiewiczJean-Pierre Mach (4 patents)Justyna IwaszkiewiczSylvie Choblet (4 patents)Justyna IwaszkiewiczJosee Golay (4 patents)Justyna IwaszkiewiczMartine Cerutti (2 patents)Justyna IwaszkiewiczJosée Golay (0 patent)Justyna IwaszkiewiczJustyna Iwaszkiewicz (4 patents)Martine CeruttiMartine Cerutti (12 patents)Vincent ZoeteVincent Zoete (9 patents)Jean KadoucheJean Kadouche (8 patents)Olivier MichielinOlivier Michielin (7 patents)Jean-Pierre MachJean-Pierre Mach (6 patents)Sylvie ChobletSylvie Choblet (4 patents)Josee GolayJosee Golay (4 patents)Martine CeruttiMartine Cerutti (3 patents)Josée GolayJosée Golay (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Centre National De La Recherche Scientifique (4 from 5,111 patents)

2. Université De Lausanne (3 from 25 patents)

3. Other (2 from 833,002 patents)

4. Azienda Socio Sanitaria Territoriale Papa Giovanni Xxiii (2 from 2 patents)

5. University of Lausanne (1 from 8 patents)

6. Azienda Ospedaliera Papa Giovanni Xxiii (1 from 1 patent)

7. Jean Kadouche (1 from 1 patent)

8. Kadouche, Jean (0 patent)


4 patents:

1. 12378325 - Multispecific antigens binding fragments and multspecific antibodies

2. 11945879 - Multispecific antigens binding fragments and multispecific antibodies

3. 10815310 - Multispecific antigen binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-kappa domains

4. 9631031 - Multispecific antigens binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-κ domains

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/22/2026
Loading…